We demonstrated that persistent KOR activation by chronic treatment with U50488, a selective KOR agonist, increased depression like symptoms in C57BL/6J mice, which were blocked by KOR antagonist norBNI and tricyclic antidepressant imipramine, but not by SSRIs fluoxetine and citalopram. The gene discussed is OPRK1; the disease is depressive symptom measurement.